Product Name
Human SSTR2 CHO-S Cell Line
Expression System
Mammalian Expression System
Concentration
Approximately 5 × 106 cells/vial
Application
This in vivo validated tumor cell line is designed for tumor modeling and preclinical evaluation of anticancer therapies. It enables assessment of tumor formation, growth kinetics, and therapeutic response in established models, and can be used for efficacy studies, pharmacological evaluation, and mechanism-of-action investigations in oncology research.
Growth Conditions
MD11 + 8 mM L-Glutamine + 8 μg/mL Puromycin
Morphology
Epitheloid cell
Growth Properties
Suspended
Mycoplasma Status
Negative
Storage
90 % FBS + 10 % DMSO
Vapor phase of liquid nitrogen
Shipping Conditions
Dry Ice
Description
The human SSTR2 CHO-S cell line binds to tidutamab, and the positive ratio of cells determined by flow cytometry is 95.6%
Industry Terms
Not Available to Industry
